Issue: December 2013
December 01, 2013
1 min read
Save

DUTCH PEERS (TWENTE II)

Issue: December 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of the safety and efficacy of a third-generation zotarolimus-eluting stent (Resolute Integrity, Medtronic) and a third-generation everolimus-eluting stent (Promus Element, Boston Scientific).